Viewing Study NCT07001592

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2026-03-13 @ 12:59 AM
Study NCT ID: NCT07001592
Status: RECRUITING
Last Update Posted: 2025-06-03
First Post: 2025-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Neoplasms View
None Esophageal Cancer View
None Liver Cancer View
None Liver Metastasis View
None MSS-CRC View
None MSS View
None Gastric Adenocarcinoma View
None Peritoneal Cancer View
None Peritoneal Carcinoma View
None Peritoneal Metastases View
None MSI-H View
None Gastric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Oncolytic virus View
None vaccinia View
None immunotherapy View
None intra-tumoral View
None intra-peritoneal View